TuHURA Biosciences, Inc.
HURA
$3.73
$0.0882.42%
12/31/2024 | 09/30/2024 | 12/31/2023 | |||
---|---|---|---|---|---|
Net Income | -6.00M | -- | -2.68M | ||
Total Depreciation and Amortization | 17.60K | -- | 36.00K | ||
Total Amortization of Deferred Charges | 171.40K | -- | 5.10K | ||
Total Other Non-Cash Items | 1.08M | -- | 108.60K | ||
Change in Net Operating Assets | 2.13M | -- | -498.10K | ||
Cash from Operations | -2.60M | -- | -3.03M | ||
Capital Expenditure | -21.40K | -- | -39.70K | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -5.99M | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | 5.19M | -- | -- | ||
Cash from Investing | -823.50K | -- | -39.70K | ||
Total Debt Issued | 0.00 | -- | 2.69M | ||
Total Debt Repaid | -796.90K | -- | -- | ||
Issuance of Common Stock | 13.80K | -- | -- | ||
Repurchase of Common Stock | -- | -- | 0.00 | ||
Issuance of Preferred Stock | -- | -- | -- | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | -2.73M | -- | -- | ||
Cash from Financing | -3.52M | -- | 2.69M | ||
Foreign Exchange rate Adjustments | -- | -- | -- | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | -6.94M | -- | -385.10K | ||